Short Interest in Indivior PLC (NASDAQ:INDV) Decreases By 20.9%

Indivior PLC (NASDAQ:INDV) was the target of a significant drop in short interest during the month of March. As of March 31st, there was short interest totalling 2,000,000 shares, a drop of 20.9% from the March 15th total of 2,530,000 shares. Currently, 1.8% of the shares of the company are sold short. Based on an average daily trading volume, of 1,370,000 shares, the short-interest ratio is currently 1.5 days.

Analysts Set New Price Targets

Several equities analysts recently issued reports on INDV shares. RODMAN&RENSHAW raised Indivior to a “strong-buy” rating in a research report on Tuesday, January 28th. Rodman & Renshaw started coverage on Indivior in a research note on Tuesday, January 28th. They issued a “buy” rating and a $16.00 price objective for the company. Finally, Piper Sandler decreased their target price on Indivior from $16.00 to $13.00 and set an “overweight” rating for the company in a report on Thursday, March 6th.

Indivior Trading Down 0.6 %

INDV traded down $0.05 during midday trading on Friday, hitting $9.01. 1,484,689 shares of the company were exchanged, compared to its average volume of 948,234. The firm has a market capitalization of $1.24 billion, a price-to-earnings ratio of -25.74 and a beta of 0.93. The company’s 50 day simple moving average is $9.50 and its 200 day simple moving average is $10.33. Indivior has a 1-year low of $7.33 and a 1-year high of $19.13.

Indivior (NASDAQ:INDV) last posted its earnings results on Thursday, February 20th. The company reported $0.32 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.32. The business had revenue of $298.00 million for the quarter, compared to analyst estimates of $262.35 million. Indivior had a negative net margin of 3.96% and a negative return on equity of 241.73%. On average, equities analysts anticipate that Indivior will post 1.22 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in INDV. Schaper Benz & Wise Investment Counsel Inc. WI acquired a new stake in shares of Indivior in the first quarter valued at about $95,000. Hennion & Walsh Asset Management Inc. raised its holdings in shares of Indivior by 48.5% during the first quarter. Hennion & Walsh Asset Management Inc. now owns 142,444 shares of the company’s stock valued at $1,357,000 after acquiring an additional 46,509 shares during the last quarter. GF Fund Management CO. LTD. purchased a new position in shares of Indivior in the fourth quarter valued at approximately $36,000. Public Employees Retirement System of Ohio boosted its stake in shares of Indivior by 32.1% in the fourth quarter. Public Employees Retirement System of Ohio now owns 39,370 shares of the company’s stock worth $505,000 after acquiring an additional 9,576 shares during the last quarter. Finally, Two Sigma Investments LP increased its position in shares of Indivior by 2.1% during the fourth quarter. Two Sigma Investments LP now owns 110,880 shares of the company’s stock worth $1,378,000 after purchasing an additional 2,237 shares in the last quarter. 60.33% of the stock is owned by institutional investors and hedge funds.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.